The eighth patent awarded to Edward Tobinick, M.D. detailing new recombinant DNA-derived methods to treat neurological and related clinical disorders was approved today by the United States Patent office. Dr. Tobinick, Assistant Clinical Professor of Medicine at UCLA, is the Medical Director of the Institute for Neurological Research (INR?), a private medical group. This patent, entitled "Interleukin Antagonists for the Treatment of Neurological, Retinal, and Muscular Disorders", U.S. Patent 6,471,961, mainly details the use of antagonists to interleukin-1 for the treatment of neurological disorders.
Read entire article